# GamaMabs Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gamamabs-pharma

- Industry: Pharmaceuticals
- Headquarters: Toulouse, France
- Website: www.gamamabs.com
- Total disclosed funding: $26M
- Latest round: Series C (Jul 16, 2020)
- Investors on record: 5

## About

GamaMabs Pharma is based in France and focuses on the development of  therapeutic antibodies to treat gynaecological cancers.

## Funding rounds

- Series C, Jul 16, 2020, $4.9M — Andera Partners, Bpifrance Investissement, IRDInov
- Series B, Jun 20, 2018, $4.1M — Andera Partners, IXO Private Equity, Bpifrance Investissement, IRDInov
- Series B, Mar 16, 2016, $17M — Andera Partners, Eiffel Investment Group, IXO Private Equity, Bpifrance Investissement, IRDInov

## Investors

- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series B, Series C
- Eiffel Investment Group (https://capitalatlas.ai/funds/eiffel-investment-group) — Series B
- IXO Private Equity (https://capitalatlas.ai/funds/ixo-private-equity) — Series B
- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Series B, Series C
- IRDInov — Series B, Series C